Media.Player

New Support Or Carrier Macromolecules

Technology Benefits

In particular, the macromolecules may be used for the delivery of drugs, genetic material, imaging components or other functional molecule to which they can be conjugated. An additional feature of the macromolecules is their ability to be targeted for certain organs, tumors, or types of tissues.

Technology Application

The present invention provides a family of dendrimers that are useful as supports, vectors, carriers or delivery vehicles for a variety of compounds in biomedical and technological applications.

Detailed Technology Description

None

Supplementary Information

Patent Number: US7097856B2
Application Number: US2001963858A
Inventor: Frechet, Jean J. | Ihre, Rolf H.
Priority Date: 29 Sep 2000
Priority Number: US7097856B2
Application Date: 25 Sep 2001
Publication Date: 29 Aug 2006
IPC Current: A61K000934 | A61K004706 | A61K004748 | C08G008300
US Class: 424486 | 514772 | 528272 | 5360231 | 549370
Assignee Applicant: The Regents of the University of California
Title: Dendrimeric support or carrier macromolecule
Usefulness: Dendrimeric support or carrier macromolecule
Summary: (I) Are useful for the preparation of wide array of dendrimers and dendrimer conjugates which are useful carriers for diverse agents including analytical, therapeutic and diagnostic agents; useful in rendering water-soluble normally insoluble drugs or other agents; useful for delivery of therapeutic, diagnostic and analytical agents both extra-and intra-cellularly, particularly genetic material, imaging components or functional molecule. The carriers are used for targeting specific organs, tumors or tissues.
Novelty: Novel anhydride for preparation of dendrimers useful as supports, vectors, carriers or delivery vehicles for variety of compounds in biomedical and technological applications

Industry

Biomedical

Sub Category

Bioengineering

Application No.

7097856

Others

Tech ID/UC Case

16986/2001-007-0

Related Cases

2001-007-0

*Abstract

The present invention provides a family of dendrimers that are useful as supports, vectors, carriers or delivery vehicles for a variety of compounds in biomedical and technological applications. In particular, the macromolecules may be used for the delivery of drugs, genetic material, imaging components or other functional molecule to which they can be conjugated. An additional feature of the macromolecules is their ability to be targeted for certain organs, tumors, or types of tissues.

*IP Issue Date

Aug 29, 2006

*Principal Investigator

Name: Jean M. J. Frechet

Department:

Name: ROLF HENRIK IHRE

Department:

Country/Region

USA